$SMTK
SmartKem, Inc.

2024 Q1 Form 10-K Financial Statement

#000155837024004098 Filed on March 27, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $0.00 $0.00 $27.00K
YoY Change -100.0% -100.0% -32.5%
Cost Of Revenue $0.00 $0.00 $23.00K
YoY Change -100.0% -100.0% -30.3%
Gross Profit $0.00 $0.00 $4.000K
YoY Change -100.0% -42.86%
Gross Profit Margin 14.81%
Selling, General & Admin $1.362M $1.163M $5.188M
YoY Change -4.95% -77.07% 2.31%
% of Gross Profit 129700.0%
Research & Development $1.276M $1.452M $5.556M
YoY Change -0.23% -74.97% -4.24%
% of Gross Profit 138900.0%
Depreciation & Amortization $63.00K $23.00K $145.0K
YoY Change 50.0% -51.06% -26.77%
% of Gross Profit 3625.0%
Operating Expenses $2.651M $2.474M $9.908M
YoY Change -6.09% -74.5% -8.88%
Operating Profit -$2.449M -$2.474M -$9.904M
YoY Change -4.11% -74.48% 2.17%
Interest Expense -$13.00K $1.068M $1.138M
YoY Change -103.29% -160.1% -164.04%
% of Operating Profit
Other Income/Expense, Net $753.0K $4.000K $267.0K
YoY Change 48.81% -115.03%
Pretax Income -$1.696M -$1.402M -$8.499M
YoY Change -17.19% -87.78% -25.91%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.696M -$1.402M -$8.499M
YoY Change -15.2% -87.8% -26.1%
Net Earnings / Revenue -31477.78%
Basic Earnings Per Share -$0.62 -$6.32
Diluted Earnings Per Share -$3.21 -$0.81 -$6.32
COMMON SHARES
Basic Shares Outstanding 1.355M 883.6K 1.345M
Diluted Shares Outstanding 2.735M 1.345M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.251M $8.836M $8.836M
YoY Change 326.53% 108.64% 108.64%
Cash & Equivalents $7.300M $8.836M $8.836M
Short-Term Investments
Other Short-Term Assets $675.0K $627.0K $627.0K
YoY Change -39.73% -24.0% -24.0%
Inventory
Prepaid Expenses
Receivables $0.00 $268.0K $268.0K
Other Receivables $1.214M $794.0K $794.0K
Total Short-Term Assets $9.140M $10.53M $10.53M
YoY Change 113.65% 63.38% 63.38%
LONG-TERM ASSETS
Property, Plant & Equipment $388.0K $740.0K $740.0K
YoY Change -32.64% 22.92% -31.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.000K $7.000K $7.000K
YoY Change 0.0% 16.67% 16.67%
Total Long-Term Assets $617.0K $747.0K $747.0K
YoY Change -39.09% -31.02% -31.02%
TOTAL ASSETS
Total Short-Term Assets $9.140M $10.53M $10.53M
Total Long-Term Assets $617.0K $747.0K $747.0K
Total Assets $9.757M $11.27M $11.27M
YoY Change 84.41% 49.79% 49.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.180M $355.0K $355.0K
YoY Change 158.77% 54.35% 54.35%
Accrued Expenses $1.032M $1.053M $1.053M
YoY Change 26.32% 18.71% 18.71%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.579M $1.768M $1.768M
YoY Change 87.43% 26.02% 26.02%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $623.0K $1.391M $1.391M
YoY Change 231.38% 482.01% 482.01%
Total Long-Term Liabilities $623.0K $1.391M $1.391M
YoY Change 231.38% 482.01% 482.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.579M $1.768M $1.768M
Total Long-Term Liabilities $623.0K $1.391M $1.391M
Total Liabilities $3.202M $3.159M $3.159M
YoY Change 104.73% 92.39% 92.39%
SHAREHOLDERS EQUITY
Retained Earnings -$103.9M -$95.07M
YoY Change 17.22% 9.78%
Common Stock $0.00 $0.00
YoY Change -100.0% -100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.555M $8.113M $8.113M
YoY Change
Total Liabilities & Shareholders Equity $9.757M $11.27M $11.27M
YoY Change 84.41% 49.79% 49.79%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$1.696M -$1.402M -$8.499M
YoY Change -15.2% -87.8% -26.1%
Depreciation, Depletion And Amortization $63.00K $23.00K $145.0K
YoY Change 50.0% -51.06% -26.77%
Cash From Operating Activities -$1.571M -$2.417M -$8.037M
YoY Change -35.43% 9.17% -11.18%
INVESTING ACTIVITIES
Capital Expenditures $6.000K $18.00K
YoY Change -50.0% -77.22%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$6.000K -$18.00K
YoY Change -50.0% -77.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $14.17M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 12.69M
YoY Change 593.5%
NET CHANGE
Cash From Operating Activities -1.571M -2.417M -8.037M
Cash From Investing Activities -6.000K -18.00K
Cash From Financing Activities 0.000 12.69M
Net Change In Cash -1.585M -2.423M 4.636M
YoY Change -37.48% 8.85% -158.02%
FREE CASH FLOW
Cash From Operating Activities -$1.571M -$2.417M -$8.037M
Capital Expenditures $6.000K $18.00K
Free Cash Flow -$2.423M -$8.055M
YoY Change 8.85% -11.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001817760
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1344892
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
827906
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
13765
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
771054
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
889668
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0286
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.32
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-13.88
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0286
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0286
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0286
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0286
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0286
CY2023 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Out Of Level3
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3
0
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-56181
CY2023 dei Entity Registrant Name
EntityRegistrantName
SmartKem, Inc.
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1083654
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
Manchester Technology Centre, Hexagon Tower.
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Delaunays Road
CY2023 dei Entity Address Address Line3
EntityAddressAddressLine3
Blackley
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Manchester
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
M9 8GQ
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
X0
CY2023 dei City Area Code
CityAreaCode
44 161
CY2023 dei Local Phone Number
LocalPhoneNumber
721 1514
CY2023 dei Security12b Title
Security12bTitle
Common stock, par value $0.0001 per share
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
889668
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
771054
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
104757000
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
3288895
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1355361
CY2023 dei Auditor Name
AuditorName
Marcum LLP
CY2023 dei Auditor Location
AuditorLocation
New York, USA
CY2023 dei Auditor Firm
AuditorFirmId
688
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8836000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4235000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
268000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
30000
CY2023Q4 smtk Research And Development Tax Credit
ResearchAndDevelopmentTaxCredit
610000
CY2022Q4 smtk Research And Development Tax Credit
ResearchAndDevelopmentTaxCredit
1121000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
811000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1056000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
10525000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
6442000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
455000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
602000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
285000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
475000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6000
CY2023Q4 us-gaap Assets
Assets
11272000
CY2022Q4 us-gaap Assets
Assets
7525000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1178000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
931000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
230000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
206000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
22000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
360000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
244000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1768000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1403000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
239000
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1372000
CY2023Q4 us-gaap Liabilities
Liabilities
3159000
CY2022Q4 us-gaap Liabilities
Liabilities
1642000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
13765
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
92933000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1578000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-483000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-95066000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-86567000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
13522000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
488000
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
658000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
880000
CY2023 smtk Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
25000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1095000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-8499000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
8113000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
8113000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5883000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11272000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7525000
CY2023 us-gaap Revenues
Revenues
27000
CY2022 us-gaap Revenues
Revenues
40000
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
23000
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
33000
CY2023 us-gaap Gross Profit
GrossProfit
4000
CY2022 us-gaap Gross Profit
GrossProfit
7000
CY2023 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
836000
CY2022 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1172000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5556000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5802000
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5188000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5071000
CY2023 smtk Foreign Currency Transaction Gain Loss Before Tax Operating
ForeignCurrencyTransactionGainLossBeforeTaxOperating
-87000
CY2023 us-gaap Operating Expenses
OperatingExpenses
10831000
CY2022 us-gaap Operating Expenses
OperatingExpenses
10873000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-9991000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-9694000
CY2023 smtk Foreign Currency Transaction Gain Loss Before Tax Nonoperating
ForeignCurrencyTransactionGainLossBeforeTaxNonoperating
1213000
CY2022 smtk Foreign Currency Transaction Gain Loss Before Tax Nonoperating
ForeignCurrencyTransactionGainLossBeforeTaxNonoperating
-1782000
CY2023 smtk Transaction Cost Allocable To Warrants
TransactionCostAllocableToWarrants
198000
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-465000
CY2023 us-gaap Interest Income Other
InterestIncomeOther
12000
CY2022 us-gaap Interest Income Other
InterestIncomeOther
5000
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1492000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1777000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8499000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11471000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-8499000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-11495000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-8499000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-11495000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1095000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
880000
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-9594000
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-10615000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.32
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-13.88
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1344892
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
827906
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5883000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
717000
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
55000
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
11027000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-11495000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5883000
CY2023 us-gaap Profit Loss
ProfitLoss
-8499000
CY2022 us-gaap Profit Loss
ProfitLoss
-11495000
CY2023 us-gaap Depreciation
Depreciation
145000
CY2022 us-gaap Depreciation
Depreciation
198000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
717000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
488000
CY2023 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
55000
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
391000
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
263000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
264000
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1120000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1782000
CY2023 smtk Transaction Cost Allocable To Warrants
TransactionCostAllocableToWarrants
198000
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-465000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
231000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
32000
CY2023 smtk Increase Decrease In Research And Development Tax Credit Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
-562000
CY2022 smtk Increase Decrease In Research And Development Tax Credit Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
213000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-70000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
42000
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
459000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-385000
CY2023 smtk Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-266000
CY2022 smtk Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-265000
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-23000
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
22000
CY2023 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
98000
CY2022 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
238000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8037000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9049000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
79000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-79000
CY2023 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
12386000
CY2023 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
1763000
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2000000
CY2023 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1483000
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
170000
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
25000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12691000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1830000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-35000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-693000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4601000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7991000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4235000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12226000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8836000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4235000
CY2023 smtk Initial Classification Of Fair Value Of Warrants
InitialClassificationOfFairValueOfWarrants
1837000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
50000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
583000
CY2022 us-gaap Stock Issued1
StockIssued1
633000
CY2023 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 17.85pt;"><span style="font-style:italic;font-weight:bold;">Reclassification</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 17.85pt;"><span style="font-style:italic;font-weight:bold;margin-left:0pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 17.85pt;">Certain accounts in the prior period consolidated financial statements have been reclassified to conform to the presentation of the current year consolidated financial statements. These reclassifications had no effect on the previously reported operating results.</p>
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-8500000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-11500000
CY2023Q2 smtk Gross Proceeds From Private Placement Preferred Stock And Warrants
GrossProceedsFromPrivatePlacementPreferredStockAndWarrants
14200000
CY2023Q2 smtk Number Of Closings Of Private Placement Of Preferred Stock And Warrants
NumberOfClosingsOfPrivatePlacementOfPreferredStockAndWarrants
2
CY2023Q2 smtk Net Proceeds From Issuance Of Private Placement Of Preferred Stock And Warrants
NetProceedsFromIssuanceOfPrivatePlacementOfPreferredStockAndWarrants
12700000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8800000
CY2022Q4 smtk Prepaid Software Licenses
PrepaidSoftwareLicenses
22000
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
104000
CY2022Q4 us-gaap Prepaid Taxes
PrepaidTaxes
195000
CY2023Q4 smtk Other Receivable And Other Prepaid Expenses
OtherReceivableAndOtherPrepaidExpenses
80000
CY2022Q4 smtk Other Receivable And Other Prepaid Expenses
OtherReceivableAndOtherPrepaidExpenses
36000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
811000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1056000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Management’s Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 17.85pt;">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingent assets and liabilities, at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The most significant estimates in the Company’s consolidated financial statements relates to the valuation of common share, fair value of share options, and the fair value of warrant liability. These estimates and assumptions are based on current facts, historical experience and various other factors believed </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 17.85pt;">to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Due to the uncertainty of factors surrounding the estimates or judgments used in the preparation of the consolidated financial statements, actual results may materially vary from these estimates. </p>
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q4 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
0
CY2023Q4 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
0
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Concentrations of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 17.85pt;">Financial instruments that potentially subject the Company to significant concentration of credit risk consist primarily of cash and cash equivalents and accounts receivable. Periodically, the Company maintains deposits in financial institutions in excess of government insured limits.</p>
CY2023Q4 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P4Y
CY2023 smtk Stock Issuance Cost
StockIssuanceCost
1500000
CY2023 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1300000
CY2022 smtk Stock Issuance Costs Allocated To Non Operating Expenses
StockIssuanceCostsAllocatedToNonOperatingExpenses
200000
CY2022 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
170000
CY2023 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
836000
CY2022 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1172000
CY2023Q4 smtk Research And Development Tax Credit
ResearchAndDevelopmentTaxCredit
610000
CY2022Q4 smtk Research And Development Tax Credit
ResearchAndDevelopmentTaxCredit
1121000
CY2023Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
160000
CY2022Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
0
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
700000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
500000
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3416467
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
109048
CY2023Q4 smtk Prepaid Facility Costs
PrepaidFacilityCosts
101000
CY2022Q4 smtk Prepaid Facility Costs
PrepaidFacilityCosts
106000
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
274000
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
358000
CY2023Q4 smtk Prepaid Professional Service Fees
PrepaidProfessionalServiceFees
68000
CY2022Q4 smtk Prepaid Professional Service Fees
PrepaidProfessionalServiceFees
339000
CY2023Q4 smtk Prepaid Research Grant Receivable
PrepaidResearchGrantReceivable
160000
CY2023Q4 smtk Prepaid Software Licenses
PrepaidSoftwareLicenses
24000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1716000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1720000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1261000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1118000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
455000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
602000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
355000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
250000
CY2022Q4 smtk Accrued Liabilities Current Lab Refurbishment
AccruedLiabilitiesCurrentLabRefurbishment
117000
CY2023Q4 smtk Accrued Technical Costs Current
AccruedTechnicalCostsCurrent
91000
CY2022Q4 smtk Accrued Technical Costs Current
AccruedTechnicalCostsCurrent
130000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
182000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
179000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
175000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
44000
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
375000
CY2022Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
211000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1178000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
931000
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
276000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
262000
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
7000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
10000
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
162000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
186000
CY2023 us-gaap Lease Cost
LeaseCost
445000
CY2022 us-gaap Lease Cost
LeaseCost
458000
CY2023 us-gaap Lease Cost
LeaseCost
445000
CY2022 us-gaap Lease Cost
LeaseCost
458000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
285000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
475000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
285000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
475000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
230000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
206000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
239000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
249000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
445000
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
266000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
265000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
50000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
583000
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y3M21D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M8D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0788
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0773
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
243000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
20000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
263000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
14000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
249000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2023 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
12700000
CY2023 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
1800000
smtk Warrants Issuance Costs Expensed
WarrantsIssuanceCostsExpensed
200000
CY2023Q2 smtk Term Of Restriction For Usage Of Cash From Operating Activities
TermOfRestrictionForUsageOfCashFromOperatingActivities
P3M
CY2023Q2 smtk Percentage Of Securities Sold In Subsequent Financing
PercentageOfSecuritiesSoldInSubsequentFinancing
0.40
CY2023 smtk Common Stock Number Of Votes Per Share
CommonStockNumberOfVotesPerShare
1
CY2023Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1429
CY2023Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1508
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.031
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.036
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.64
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
80887
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
63.31
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y9M7D
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
34.37
CY2023 smtk Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Expired Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExpiredNumberOfShares
10476
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
64.96
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
70411
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
63.07
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M10D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
33.98
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
42713
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
58.57
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y9M3D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
39520
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
717000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
488000
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
700000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-2299000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
584000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-6200000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-12055000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8499000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11471000
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.014
CY2023 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.018
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.029
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.016
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
-0.074
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
-0.063
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.169
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.179
CY2023 smtk Effective Income Tax Rate Reconciliation Warrant Revaluation Percent
EffectiveIncomeTaxRateReconciliationWarrantRevaluationPercent
0.011
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.034
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.001
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.002
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
22000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
24000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
10874000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
9151000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
207000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
187000
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
114000
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
150000
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
45000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
-119000
CY2023Q4 smtk Deferred Tax Assets And Liabilities Gross
DeferredTaxAssetsAndLiabilitiesGross
11012000
CY2022Q4 smtk Deferred Tax Assets And Liabilities Gross
DeferredTaxAssetsAndLiabilitiesGross
9069000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11012000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9069000
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
155000
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
160000
CY2023Q4 smtk Defined Contribution Plan Due To Pension Fund
DefinedContributionPlanDueToPensionFund
5000
CY2022Q4 smtk Defined Contribution Plan Due To Pension Fund
DefinedContributionPlanDueToPensionFund
1000
CY2023 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Into Level3
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3
0
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1372000
CY2023Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
1372000
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 smtk Non Rule10b51 Arr Modified Flag
NonRule10b51ArrModifiedFlag
false
CY2023Q4 smtk Rule10b51 Arr Modified Flag
Rule10b51ArrModifiedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001558370-24-004098-index-headers.html Edgar Link pending
0001558370-24-004098-index.html Edgar Link pending
0001558370-24-004098.txt Edgar Link pending
0001558370-24-004098-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
smtk-20231231.xsd Edgar Link pending
smtk-20231231x10k.htm Edgar Link pending
smtk-20231231xex10d28.htm Edgar Link pending
smtk-20231231xex23d1.htm Edgar Link pending
smtk-20231231xex23d2.htm Edgar Link pending
smtk-20231231xex31d1.htm Edgar Link pending
smtk-20231231xex31d2.htm Edgar Link pending
smtk-20231231xex32d1.htm Edgar Link pending
smtk-20231231xex32d2.htm Edgar Link pending
smtk-20231231xex3d1.htm Edgar Link pending
smtk-20231231xex4d4.htm Edgar Link pending
smtk-20231231_def.xml Edgar Link unprocessable
smtk-20231231_lab.xml Edgar Link unprocessable
smtk-20231231_pre.xml Edgar Link unprocessable
smtk-20231231x10k_htm.xml Edgar Link completed
smtk-20231231_cal.xml Edgar Link unprocessable